Island Raises $60 Million in Series B Extension  

by Kay Aloha Villamor in November 15th, 2022

Island, a Dallas, Texas-based-based developer of an enterprise browser, raised $60 million in a Series B extension funding round led by Georgian. 

This investment will further fuel Island’s mission to reshape the future of work by redefining the role of the browser for the enterprise. 

The Georgian investment reaffirms Island's $1.3 billion Series B valuation and brings overall investment in the company to more than $250 million. 

“The market adoption of our technology has been exciting, and being able to further validate our valuation, even with the headwinds facing the broader market, is an honor,” said Mike Fey, Island CEO and Co-Founder. “This most recent investment adds to our considerable war chest, and we see great opportunity to leverage it to expand our leadership position and continue to bring game-changing value to our customers. We are grateful to all of our investors for their belief in, and support of, Island, and excited to bring on another very strong partner in Georgian.”

Georgian will contribute expertise in deep data science, in addition to funding, to further accelerate the security and productivity functionality of the Island Enterprise Browser.

The Island Enterprise Browser was recently named the Best Enterprise Security Product of the Year by SC Magazine.

Company: Island Technology, Inc.

Raised: $60.0M

Round: Series B Extension

Funding Month: November 2022

Lead Investors: Georgian

Additional Investors: 

Company Website:

Software Category: Enterprise Browser

About the Company: Island is the developer of the Enterprise Browser – the ideal enterprise workplace, where work flows freely while remaining fundamentally secure. With the core needs of the enterprise naturally embedded in the browser itself, Island gives organizations complete control, visibility, and governance over the last mile, while delivering the same smooth Chromium-based browser experience users expect. Island is based in Dallas with research and development in Tel Aviv.


Your cart